Treatment of psoriatic arthritis with antitumour necrosis factor-α antibody clears skin lesions of psoriasis resistant to treatment with methotrexate
Data up to Jan 2025
Total Citations Per Year
Abstract
References (11)
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
1994 • 1,695 citations
Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
1994 • 481 citations
Inflammatory Skin Diseases, T Cells, and Immune Surveillance
1999 • 474 citations
T Cells Involved in Psoriasis Vulgaris Belong to the Th1 Subset
1994 • 451 citations
Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study
2000 • 298 citations
The pathogenesis of psoriasis: immunological facts and speculations
1999 • 286 citations
Treatment with anti-tumor necrosis factor α (TNF-α) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
2000 • 228 citations
Methotrexate Therapy of Psoriasis: Differential Sensitivity of Proliferating Lymphoid and Epithelial Cells to the Cytotoxic and Growth-Inhibitory Effects of Methotrexate
1995 • 133 citations
EPIDEMIOLOGICAL ASPECTS OF PSORIASIS AND ARTHRITIS
1966 • 101 citations
The role of superantigens in human diseases: therapeutic implications for the treatment of skin diseases
1998 • 83 citations
Deleted Work
1955 • 0 citations